SSRP1 and rheumatoid arthritis: Both MIAT and miR-204-5p have been reported to be closely associated with RA, and studies have shown that miR-204 affects synovial hyperplasia and inflammation of RA by regulating structure-specific recognition protein 1 (Ssrp1), suggesting that miR-204 can be used as a novel biomarker for the treatment of RA36.